30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Immune Design Corp (IMDZ)

Track

Stock chart
Ticker: IMDZ Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Brady Stephen R
EVP, Strategy & Finance
1 sale — total 8,722 USD
Planned sale 7 Jan 2019
Value US$1,791,546.79 | Price 277.36 | Shares 28,565
Planned sale 7 Jan 2019
Value US$2,837,201.58 | Price 120.62 | Shares 89,516
Planned sale 7 Jan 2019
Value US$20,590.75 | Price 1.58 | Shares 13,014
Planned sale 7 Jan 2019
Value US$5,414.60 | Price 1.59 | Shares 3,414
Sale 4 Dec 2018
Value US$164,928.65 | Price 1.83 | Shares 89,948
Sale 4 Dec 2018
Value US$700,466.37 | Price 1.83 | Shares 382,017
Sale 4 Dec 2018
Value US$788,512.18 | Price 1.83 | Shares 430,035
Planned sale 5 Jan 2018
Value US$8,281.62 | Price 4.17 | Shares 1,986
Planned sale 5 Jan 2018
Value US$33,246.86 | Price 4.17 | Shares 7,970
Planned sale 5 Jan 2018
Value US$8,281.82 | Price 4.17 | Shares 1,986
Planned sale 5 Jan 2018
Value US$13,884.75 | Price 4.17 | Shares 3,328
Sale 4 Jan 2018
Value US$2,816.44 | Price 4.17 | Shares 675
Buy 2 Nov 2017
Value US$225,000.00 | Price 4.50 | Shares 50,000
Buy 30 Oct 2017
Value US$114,375.00 | Price 4.58 | Shares 25,000
Buy 27 Oct 2017
Value US$264,751.50 | Price 4.07 | Shares 65,000
Buy 27 Oct 2017
Value US$10,992,100.00 | Price 4.10 | Shares 2,681,000
Buy 27 Oct 2017
Value US$10,992,100.00 | Price 4.10 | Shares 2,681,000
Buy 25 Oct 2017
Value US$106,620.00 | Price 4.26 | Shares 25,000
Planned sale 1 Aug 2017
Value US$8,813.11 | Price 11.80 | Shares 747
Planned sale 1 Aug 2017
Value US$105,523.06 | Price 11.40 | Shares 9,253
Buy 11 Jul 2017
Value US$18,650.00 | Price 9.33 | Shares 2,000
Buy 10 Jul 2017
Value US$89,950.00 | Price 9.00 | Shares 10,000
Buy 7 Jul 2017
Value US$36,600.00 | Price 9.15 | Shares 4,000
Buy 6 Jul 2017
Value US$37,550.00 | Price 9.39 | Shares 4,000
Buy 10 May 2017
Value US$30,700.00 | Price 6.14 | Shares 5,000
Buy 9 May 2017
Value US$6,050.00 | Price 6.05 | Shares 1,000
Buy 9 May 2017
Value US$36,360.00 | Price 6.06 | Shares 6,000
Buy 9 May 2017
Value US$80,548.90 | Price 6.07 | Shares 13,270
Buy 9 May 2017
Value US$28,947.60 | Price 6.12 | Shares 4,730
Planned sale 4 Jan 2017
Value US$5,243.00 | Price 5.35 | Shares 980
Planned sale 4 Jan 2017
Value US$21,079.00 | Price 5.35 | Shares 3,940
Planned sale 4 Jan 2017
Value US$8,784.70 | Price 5.35 | Shares 1,642
Planned sale 4 Jan 2017
Value US$5,243.00 | Price 5.35 | Shares 980
Sale 22 Dec 2016
Value US$62,039.00 | Price 6.20 | Shares 10,000
Sale 16 Dec 2016
Value US$327,330.00 | Price 6.55 | Shares 50,000
Buy 20 Sep 2016
Value US$5,000,000.00 | Price 6.25 | Shares 800,000
Buy 20 Sep 2016
Value US$250,000.00 | Price 6.25 | Shares 40,000
Buy 20 Sep 2016
Value US$5,000,000.00 | Price 6.25 | Shares 800,000
Buy 15 Jul 2016
Value US$10,255.35 | Price 6.84 | Shares 1,500
Planned sale 23 Nov 2015
Value US$100,000.00 | Price 20.00 | Shares 5,000
Planned sale 14 Sep 2015
Value US$80,955.00 | Price 16.19 | Shares 5,000
Buy 25 Aug 2015
Value US$43,500.00 | Price 14.50 | Shares 3,000
Sale 12 May 2015
Value US$3,332,500.00 | Price 21.50 | Shares 155,000
Sale 12 May 2015
Value US$503,231.82 | Price 22.26 | Shares 22,607
Sale 24 Apr 2015
Value US$666,000.00 | Price 26.64 | Shares 25,000
Sale 23 Apr 2015
Value US$619,286.05 | Price 27.35 | Shares 22,643
Sale 23 Apr 2015
Value US$266,400.00 | Price 26.64 | Shares 10,000
Sale 22 Apr 2015
Value US$670,613.44 | Price 26.56 | Shares 25,249
Sale 21 Apr 2015
Value US$373,300.45 | Price 26.35 | Shares 14,167
Buy 21 Apr 2015
Value US$662,500.00 | Price 26.50 | Shares 25,000
Buy 21 Apr 2015
Value US$265,000.00 | Price 26.50 | Shares 10,000
Sale 20 Apr 2015
Value US$338,220.48 | Price 26.44 | Shares 12,792
Sale 17 Apr 2015
Value US$503,022.87 | Price 26.67 | Shares 18,861
Sale 16 Apr 2015
Value US$2,675.00 | Price 26.75 | Shares 100
Sale 15 Apr 2015
Value US$2,917.00 | Price 29.17 | Shares 100
Sale 15 Apr 2015
Value US$1,139,943.00 | Price 28.57 | Shares 39,900
Sale 14 Apr 2015
Value US$376,569.64 | Price 27.26 | Shares 13,814
Sale 7 Apr 2015
Value US$95,580.00 | Price 26.55 | Shares 3,600
Sale 6 Apr 2015
Value US$104,697.60 | Price 26.88 | Shares 3,895
Sale 1 Apr 2015
Value US$217,507.45 | Price 27.07 | Shares 8,035
Sale 1 Apr 2015
Value US$1,057,194.45 | Price 26.55 | Shares 39,819
Sale 1 Apr 2015
Value US$372,446.00 | Price 25.51 | Shares 14,600
Sale 25 Mar 2015
Value US$136,587.36 | Price 27.56 | Shares 4,956
Sale 24 Mar 2015
Value US$365,244.00 | Price 27.67 | Shares 13,200
Sale 23 Mar 2015
Value US$138,900.00 | Price 27.78 | Shares 5,000
Sale 20 Mar 2015
Value US$2,364.60 | Price 28.15 | Shares 84
Sale 20 Mar 2015
Value US$11,252.00 | Price 28.13 | Shares 400
Sale 20 Mar 2015
Value US$5,608.00 | Price 28.04 | Shares 200
Sale 20 Mar 2015
Value US$238,749.27 | Price 27.19 | Shares 8,780
Sale 19 Mar 2015
Value US$5,614.00 | Price 28.07 | Shares 200
Sale 19 Mar 2015
Value US$820,990.00 | Price 27.55 | Shares 29,800
Sale 18 Mar 2015
Value US$2,702.00 | Price 27.02 | Shares 100
Sale 18 Mar 2015
Value US$13,495.00 | Price 26.99 | Shares 500
Sale 18 Mar 2015
Value US$2,704.00 | Price 27.04 | Shares 100
Sale 18 Mar 2015
Value US$512,608.00 | Price 26.56 | Shares 19,300
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-01-07 2019-01-07 PlS Planned sale
Brady Stephen R

EVP, Strategy & Finance

Officer
28,565 -3.2%
277.36
US$1,791,547 		28,565 -3.2% 277.36 US$1,791,547
2019-01-07 2019-01-07 PlS Planned sale
Yurasov Sergey

Sr. VP, Clinic. Devel. & CMO

Officer
89,516 -11.4%
120.62
US$2,837,202 		89,516 -11.4% 120.62 US$2,837,202
2019-01-07 2019-01-07 PlS Planned sale
0.5
Paya Carlos V

President and CEO

Executive Director
70,251 -1.1%
56.58
US$2,824,968 		70,251 -1.1% 56.58 US$2,824,968
2019-01-07 2019-01-07 PlS Planned sale
ter Meulen Jan Henrik

Chief Scientific Officer

Officer
3,414 -3.9%
1.59
US$5,415 		3,414 -3.9% 1.59 US$5,415
2018-12-04 2018-12-04 S Sale BVF PARTNERS L P/IL Large shareholder
89,948 -19.5%
1.83
US$164,929 		89,948 -19.5% 1.83 US$164,929
2018-12-04 2018-12-04 S Sale BVF PARTNERS L P/IL Large shareholder
382,017 -16.4%
1.83
US$700,466 		382,017 -16.4% 1.83 US$700,466
2018-12-04 2018-12-04 S Sale BVF PARTNERS L P/IL Large shareholder
430,035 -14.7%
1.83
US$788,512 		430,035 -14.7% 1.83 US$788,512
2018-01-08 2018-01-05 PlS Planned sale ter Meulen Jan Henrik

Chief Scientific Officer

Officer
1,986 -4.8%
4.17
US$8,282 		1,986 -4.8% 4.17 US$8,282
2018-01-08 2018-01-05 PlS Planned sale
0.5
Paya Carlos V

President and CEO

Executive Director
7,970 -7.0%
4.17
US$33,247 		7,970 -7.0% 4.17 US$33,247
2018-01-08 2018-01-05 PlS Planned sale
Gombotz Wayne

Chief Development Officer

Officer
1,986 -5.1%
4.17
US$8,282 		1,986 -5.1% 4.17 US$8,282
2018-01-08 2018-01-05 PlS Planned sale
Brady Stephen R

EVP, Strategy & Finance

Officer
3,328 -6.6%
4.17
US$13,885 		3,328 -6.6% 4.17 US$13,885
2018-01-05 2018-01-04 S Sale Yurasov Sergey

Sr. VP, Clinic. Devel. & CMO

Officer
675 -2.4%
4.17
US$2,816 		675 -2.4% 4.17 US$2,816
2017-11-06 2017-11-02 B Purchase COLEMAN LEWIS W
50,000 +40.0%
4.50
US$225,000 		50,000 +40.0% 4.50 US$225,000
2017-11-01 2017-10-30 B Purchase BERGER FRANKLIN M
25,000 +50.0%
4.58
US$114,375 		25,000 +50.0% 4.58 US$114,375
2017-10-31 2017-10-27 B Purchase COLEMAN LEWIS W
65,000 +108.3%
4.07
US$264,752 		65,000 +108.3% 4.07 US$264,752
2017-10-30 2017-10-27 B Purchase COLUMN GROUP L P Large shareholder
2,681,000 +67.7%
4.10
US$10,992,100 		2,681,000 +67.7% 4.10 US$10,992,100
2017-10-27 2017-10-27 B Purchase Svennilson Peter Non-Executive Director Large shareholder
2,681,000 +inf%
4.10
US$10,992,100 		2,681,000 +inf% 4.10 US$10,992,100
2017-10-26 2017-10-25 B Purchase BERGER FRANKLIN M
25,000 +100.0%
4.26
US$106,620 		25,000 +100.0% 4.26 US$106,620
2017-08-03 2017-08-01 PlS Planned sale Gombotz Wayne

Chief Development Officer
747 -3.1%
11.80
US$8,813 		747 -3.1% 11.80 US$8,813
2017-08-03 2017-08-01 PlS Planned sale Gombotz Wayne

Chief Development Officer
9,253 -28.0%
11.40
US$105,523 		9,253 -28.0% 11.40 US$105,523
2017-07-12 2017-07-11 B Purchase COLEMAN LEWIS W Non-Executive Director
2,000 +11.1%
9.33
US$18,650 		2,000 +11.1% 9.33 US$18,650
2017-07-12 2017-07-10 B Purchase COLEMAN LEWIS W Non-Executive Director
10,000 +125.0%
9.00
US$89,950 		10,000 +125.0% 9.00 US$89,950
2017-07-10 2017-07-07 B Purchase COLEMAN LEWIS W Non-Executive Director
4,000 +100.0%
9.15
US$36,600 		4,000 +100.0% 9.15 US$36,600
2017-07-10 2017-07-06 B Purchase COLEMAN LEWIS W Non-Executive Director
4,000 +inf%
9.39
US$37,550 		4,000 +inf% 9.39 US$37,550
2017-05-22 2017-05-10 B Purchase GUTHART LEO Large shareholder
5,000 +0.2%
6.14
US$30,700 		5,000 +0.2% 6.14 US$30,700
2017-05-22 2017-05-09 B Purchase GUTHART LEO Large shareholder
1,000 +0.0%
6.05
US$6,050 		1,000 +0.0% 6.05 US$6,050
2017-05-22 2017-05-09 B Purchase GUTHART LEO Large shareholder
6,000 +0.2%
6.06
US$36,360 		6,000 +0.2% 6.06 US$36,360
2017-05-22 2017-05-09 B Purchase GUTHART LEO Large shareholder
13,270 +0.4%
6.07
US$80,549 		13,270 +0.4% 6.07 US$80,549
2017-05-22 2017-05-09 B Purchase GUTHART LEO Large shareholder
4,730 +0.2%
6.12
US$28,948 		4,730 +0.2% 6.12 US$28,948
2017-01-06 2017-01-04 PlS Planned sale ter Meulen Jan Henrik

Chief Scientific Officer
980 -4.1%
5.35
US$5,243 		980 -4.1% 5.35 US$5,243
2017-01-06 2017-01-04 PlS Planned sale
0.5
Paya Carlos V

President and CEO

Executive Director
3,940 -5.5%
5.35
US$21,079 		3,940 -5.5% 5.35 US$21,079
2017-01-06 2017-01-04 PlS Planned sale
Brady Stephen R

EVP, Strategy & Finance
1,642 -5.1%
5.35
US$8,785 		1,642 -5.1% 5.35 US$8,785
2017-01-06 2017-01-04 PlS Planned sale
Gombotz Wayne

Chief Development Officer
980 -4.1%
5.35
US$5,243 		980 -4.1% 5.35 US$5,243
2016-12-27 2016-12-22 S Sale COLEMAN LEWIS W Non-Executive Director
10,000 -20.0%
6.20
US$62,039 		10,000 -20.0% 6.20 US$62,039
2016-12-20 2016-12-16 S Sale BERGER FRANKLIN M Non-Executive Director
50,000 -66.7%
6.55
US$327,330 		50,000 -66.7% 6.55 US$327,330
2016-09-22 2016-09-20 B Purchase COLUMN GROUP L P Large shareholder
800,000 +25.3%
6.25
US$5,000,000 		800,000 +25.3% 6.25 US$5,000,000
2016-09-20 2016-09-20 B Purchase COLEMAN LEWIS W Non-Executive Director
40,000 +400.0%
6.25
US$250,000 		40,000 +400.0% 6.25 US$250,000
2016-09-20 2016-09-20 B Purchase Svennilson Peter Non-Executive Director Large shareholder
800,000 +inf%
6.25
US$5,000,000 		800,000 +inf% 6.25 US$5,000,000
2016-07-19 2016-07-15 B Purchase Brady Stephen R

EVP, Strategy & Finance

Officer
1,500 +9.6%
6.84
US$10,255 		1,500 +9.6% 6.84 US$10,255
2015-11-24 2015-11-23 PlS Planned sale Gombotz Wayne

Chief Development Officer

Officer
5,000 -99.3%
20.00
US$100,000 		5,000 -99.3% 20.00 US$100,000
2015-09-16 2015-09-14 PlS Planned sale Gombotz Wayne

Chief Development Officer

Officer
5,000 -99.3%
16.19
US$80,955 		5,000 -99.3% 16.19 US$80,955
2015-08-26 2015-08-25 B Purchase COLEMAN LEWIS W Non-Executive Director
3,000 +inf%
14.50
US$43,500 		3,000 +inf% 14.50 US$43,500
2015-05-13 2015-05-12 S Sale ProQuest Investments IV, L.P. Large shareholder
155,000 -7.2%
21.50
US$3,332,500 		155,000 -7.2% 21.50 US$3,332,500
2015-05-13 2015-05-12 S Sale ProQuest Investments IV, L.P. Large shareholder
22,607 -1.0%
22.26
US$503,232 		22,607 -1.0% 22.26 US$503,232
2015-04-24 2015-04-24 S Sale ProQuest Investments IV, L.P. Large shareholder
25,000 -1.1%
26.64
US$666,000 		25,000 -1.1% 26.64 US$666,000
2015-04-24 2015-04-23 S Sale ProQuest Investments IV, L.P. Large shareholder
22,643 -1.0%
27.35
US$619,286 		22,643 -1.0% 27.35 US$619,286
2015-04-24 2015-04-23 S Sale ProQuest Investments IV, L.P. Large shareholder
10,000 -0.5%
26.64
US$266,400 		10,000 -0.5% 26.64 US$266,400
2015-04-24 2015-04-22 S Sale ProQuest Investments IV, L.P. Large shareholder
25,249 -1.1%
26.56
US$670,613 		25,249 -1.1% 26.56 US$670,613
2015-04-21 2015-04-21 S Sale ProQuest Investments IV, L.P. Large shareholder
14,167 -0.6%
26.35
US$373,300 		14,167 -0.6% 26.35 US$373,300
2015-04-21 2015-04-21 B Purchase BERGER FRANKLIN M Non-Executive Director
25,000 +50.0%
26.50
US$662,500 		25,000 +50.0% 26.50 US$662,500
2015-04-21 2015-04-21 B Purchase COLEMAN LEWIS W Non-Executive Director
10,000 +inf%
26.50
US$265,000 		10,000 +inf% 26.50 US$265,000
2015-04-21 2015-04-20 S Sale ProQuest Investments IV, L.P. Large shareholder
12,792 -0.6%
26.44
US$338,220 		12,792 -0.6% 26.44 US$338,220
2015-04-21 2015-04-17 S Sale ProQuest Investments IV, L.P. Large shareholder
18,861 -0.8%
26.67
US$503,023 		18,861 -0.8% 26.67 US$503,023
2015-04-16 2015-04-16 S Sale ProQuest Investments IV, L.P. Large shareholder
100 -0.0%
26.75
US$2,675 		100 -0.0% 26.75 US$2,675
2015-04-16 2015-04-15 S Sale ProQuest Investments IV, L.P. Large shareholder
100 -0.0%
29.17
US$2,917 		100 -0.0% 29.17 US$2,917
2015-04-16 2015-04-15 S Sale ProQuest Investments IV, L.P. Large shareholder
39,900 -1.7%
28.57
US$1,139,943 		39,900 -1.7% 28.57 US$1,139,943
2015-04-16 2015-04-14 S Sale ProQuest Investments IV, L.P. Large shareholder
13,814 -0.6%
27.26
US$376,570 		13,814 -0.6% 27.26 US$376,570
2015-04-08 2015-04-07 S Sale ProQuest Investments IV, L.P. Large shareholder
3,600 -0.2%
26.55
US$95,580 		3,600 -0.2% 26.55 US$95,580
2015-04-08 2015-04-06 S Sale ProQuest Investments IV, L.P. Large shareholder
3,895 -0.2%
26.88
US$104,698 		3,895 -0.2% 26.88 US$104,698
2015-04-02 2015-04-01 S Sale ProQuest Investments IV, L.P. Large shareholder
8,035 -0.3%
27.07
US$217,507 		8,035 -0.3% 27.07 US$217,507
2015-04-02 2015-04-01 S Sale ProQuest Investments IV, L.P. Large shareholder
39,819 -1.7%
26.55
US$1,057,194 		39,819 -1.7% 26.55 US$1,057,194
2015-04-02 2015-04-01 S Sale ProQuest Investments IV, L.P. Large shareholder
14,600 -0.6%
25.51
US$372,446 		14,600 -0.6% 25.51 US$372,446
2015-03-26 2015-03-25 S Sale ProQuest Investments IV, L.P. Large shareholder
4,956 -0.2%
27.56
US$136,587 		4,956 -0.2% 27.56 US$136,587
2015-03-26 2015-03-24 S Sale ProQuest Investments IV, L.P. Large shareholder
13,200 -0.5%
27.67
US$365,244 		13,200 -0.5% 27.67 US$365,244
2015-03-23 2015-03-23 S Sale ProQuest Investments IV, L.P. Large shareholder
5,000 -0.2%
27.78
US$138,900 		5,000 -0.2% 27.78 US$138,900
2015-03-23 2015-03-20 S Sale ProQuest Investments IV, L.P. Large shareholder
84 -0.0%
28.15
US$2,365 		84 -0.0% 28.15 US$2,365
2015-03-23 2015-03-20 S Sale ProQuest Investments IV, L.P. Large shareholder
400 -0.0%
28.13
US$11,252 		400 -0.0% 28.13 US$11,252
2015-03-23 2015-03-20 S Sale ProQuest Investments IV, L.P. Large shareholder
200 -0.0%
28.04
US$5,608 		200 -0.0% 28.04 US$5,608
2015-03-23 2015-03-20 S Sale ProQuest Investments IV, L.P. Large shareholder
8,780 -0.4%
27.19
US$238,749 		8,780 -0.4% 27.19 US$238,749
2015-03-23 2015-03-19 S Sale ProQuest Investments IV, L.P. Large shareholder
200 -0.0%
28.07
US$5,614 		200 -0.0% 28.07 US$5,614
2015-03-23 2015-03-19 S Sale ProQuest Investments IV, L.P. Large shareholder
29,800 -1.2%
27.55
US$820,990 		29,800 -1.2% 27.55 US$820,990
2015-03-18 2015-03-18 S Sale ProQuest Investments IV, L.P. Large shareholder
100 -0.0%
27.02
US$2,702 		100 -0.0% 27.02 US$2,702
2015-03-18 2015-03-18 S Sale ProQuest Investments IV, L.P. Large shareholder
500 -0.0%
26.99
US$13,495 		500 -0.0% 26.99 US$13,495
2015-03-18 2015-03-18 S Sale ProQuest Investments IV, L.P. Large shareholder
100 -0.0%
27.04
US$2,704 		100 -0.0% 27.04 US$2,704
2015-03-18 2015-03-18 S Sale ProQuest Investments IV, L.P. Large shareholder
19,300 -0.8%
26.56
US$512,608 		19,300 -0.8% 26.56 US$512,608
Explore more

More insider trading research around Immune Design Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America